Site Search
Recent Posts
Newsletter Sign Up
Categories
- General (2)
- Research (68)
- Gene Therapy (30)
- Stem Cell (23)
- Pharmaceuticals (19)
- Genetics (15)
- Prosthetics (17)
- Diseases (62)
- AMD (35)
- Retinitis pigmentosa (36)
- Stargardt disease (32)
- Usher syndrome (34)
- LCA (27)
- Other diseases (23)
- Support (13)
- News Commentary (15)
- FFB on the Road (29)
- VISIONS (11)
- Guest Bloggers (12)
- Reader Questions Answered (2)
Archives
Blogroll
Tags
advanced cell technology
age-related macular degeneration
artificial retina
arvo
bascom palmer eye institute
clinical trials
cochlear implant
dha
dining in the dark
fda
food and drug administration
gene-correction
genentech
genetic testing
hadassah
ipsc
israel
lca
leber congenital amaurosis
mainz university
mobility
mutated genes
oshu
oxford biomedica
proteins
rabin medical center
radboud university
retina foundation of the southwest
retina implant ag
retinal imaging
retinitis pigmentosa
ribosomes
rods
rp
second sight
stargardt disease
Stem Cells
technology
transplantation
university of california
university of wisconson-madison
usher syndrome
visions
vitamin a
wills eye institute
Posts Tagged ‘stargardt’
Two days ago, as part of FFB’s “Light the Way to a Cure” fundraising campaign, I shared the story of Corey Haas, as an example of clinical trial participants benefitting from gene therapy studies the Foundation supports. In his case, the therapy’s for a retinal disease called Leber congenital amaurosis. Today, I’d like to share the story of Dick Coulson (pictured, left), who has age-related macular degeneration (AMD), the leading cause of blindness in people age 55 and older. It’s also the target of two treatments that are currently in clinical, or human, trials, both of which are derived from stem cells.
Read more






